
Lode J. Swinnen
Oncology | Hematology | Hematology Oncology
Weinberg BLDG
Baltimore, MD 21287
Baltimore, MD 21287
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: July 25, 2025
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2024
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 07, 2023
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Journal: Nature
Published: April 19, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 12, 2023
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Journal: Transplantation and cellular therapy
Published: October 13, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Journal: Transplantation and cellular therapy
Published: October 05, 2022
Last Updated: 09/26/2026